ct1812
Showing 1 - 8 of 8
Alzheimer Trial in Amsterdam (CT1812, Placebo)
Recruiting
- Alzheimer Disease
- CT1812
- Placebo
-
Amsterdam, NetherlandsBrain Research Center
Nov 9, 2022
Alzheimer Trial in DeLand (CT1812)
Completed
- Alzheimer Disease
- CT1812
-
DeLand, FloridaAccel Clinical Research
Jun 16, 2022
Alzheimer Trial in New York, Philadelphia (CT1812, Placebo)
Completed
- Alzheimer Disease
- CT1812
- Placebo
-
New York, New York
- +1 more
Jan 10, 2022
Mild to Moderate Alzheimer's Disease Trial in Australia, United States (CT1812, Placebo)
Recruiting
- Mild to Moderate Alzheimer's Disease
- CT1812
- Placebo
-
Phoenix, Arizona
- +18 more
Aug 16, 2022
Dementia With Lewy Bodies Trial in United States (CT1812)
Recruiting
- Dementia With Lewy Bodies
- CT1812
-
Phoenix, Arizona
- +29 more
Jan 25, 2023
Healthy Volunteers Trial in Kalamazoo (CT1812, tolbutamide, dextromethorphan)
Completed
- Healthy Volunteers
- CT1812
- +4 more
-
Kalamazoo, MichiganJasper Clinic
Oct 15, 2018
Alzheimer's Disease Trial in Australia (CT1812, Placebo)
Completed
- Alzheimer's Disease
- CT1812
- Placebo
-
Southport, Queensland, Australia
- +3 more
Jul 24, 2018
Cognitive Impairment Trial in Melbourne (CT1812, Placebo)
Completed
- Cognitive Impairment
- CT1812
- Placebo
-
Melbourne, Victoria, AustraliaNucleus Network Limited
Sep 5, 2016